JD Health International Inc.
6618.HKI doubted this one. Five lenses on the market agreed at once, almost never happens. Rare. JD Health stamps prescriptions before medicine ships to you, and value models revised the price two thirds higher.
- Fair value according to the model56.5% above the priceThe model puts fair value 56.5% above today's price. It weighs earnings, growth and risk.
- Earnings estimatesflatearnings estimates are barely moving
- How it ran against the rest13.6%Over the past period this stock did better than 14% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
- Company value on the exchange$14.7 bnAll shares together are worth about $14.7 billion. That makes it a solid mid-sized company.
- How far below the year's high48% below the highThe highest price of the past year was 68.75 dollars; today it trades 48 percent lower. A gap like that can be an opportunity, but it can also be there because something genuinely changed at the company.
- Is revenue still growing+26.3% in a yearRevenue grew 26.3 percent over the past year. That is the foundation under everything above.
- Are profits growing too+29% profitProfit changed by 29 percent against 26 percent of revenue. Profit is growing faster than revenue, which is exactly what you want to see: the company gets more efficient as it grows.